193 related articles for article (PubMed ID: 20951464)
1. Sex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cells.
Uppstad H; Osnes GH; Cole KJ; Phillips DH; Haugen A; Mollerup S
Lung Cancer; 2011 Mar; 71(3):264-70. PubMed ID: 20951464
[TBL] [Abstract][Full Text] [Related]
2. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.
Mollerup S; Berge G; Baera R; Skaug V; Hewer A; Phillips DH; Stangeland L; Haugen A
Int J Cancer; 2006 Aug; 119(4):741-4. PubMed ID: 16557573
[TBL] [Abstract][Full Text] [Related]
4. Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung.
Berge G; Mollerup S; ØVrebø S; Hewer A; Phillips DH; Eilertsen E; Haugen A
Lung Cancer; 2004 Sep; 45(3):289-97. PubMed ID: 15301869
[TBL] [Abstract][Full Text] [Related]
5. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
[TBL] [Abstract][Full Text] [Related]
6. Effects of human blood levels of two PAH mixtures on the AHR signalling activation pathway and CYP1A1 and COMT target genes in granulosa non-tumor and granulosa tumor cell lines.
Zajda K; Ptak A; Rak A; Fiedor E; Grochowalski A; Milewicz T; Gregoraszczuk EL
Toxicology; 2017 Aug; 389():1-12. PubMed ID: 28710019
[TBL] [Abstract][Full Text] [Related]
7. The resveratrol analogue, 2,3',4,5'-tetramethoxystilbene, does not inhibit CYP gene expression, enzyme activity and benzo[a]pyrene-DNA adduct formation in MCF-7 cells exposed to benzo[a]pyrene.
Einem Lindeman T; Poirier MC; Divi RL
Mutagenesis; 2011 Sep; 26(5):629-35. PubMed ID: 21669939
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
Takemura H; Nagayoshi H; Matsuda T; Sakakibara H; Morita M; Matsui A; Ohura T; Shimoi K
Toxicology; 2010; 274(1-3):42-8. PubMed ID: 20553787
[TBL] [Abstract][Full Text] [Related]
9. Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1.
Courter LA; Musafia-Jeknic T; Fischer K; Bildfell R; Giovanini J; Pereira C; Baird WM
Toxicol Sci; 2007 Jan; 95(1):63-73. PubMed ID: 17060372
[TBL] [Abstract][Full Text] [Related]
10. Differential response to benzo[A]pyrene in human lung adenocarcinoma cell lines: the absence of aryl hydrocarbon receptor activation.
Chang KW; Lee H; Wang HJ; Chen SY; Lin P
Life Sci; 1999; 65(13):1339-49. PubMed ID: 10503953
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of β-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation.
Kabátková M; Zapletal O; Tylichová Z; Neča J; Machala M; Milcová A; Topinka J; Kozubík A; Vondráček J
Mutagenesis; 2015 Jul; 30(4):565-76. PubMed ID: 25805023
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 90 inhibitors suppress aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and DNA adduct formation.
Hughes D; Guttenplan JB; Marcus CB; Subbaramaiah K; Dannenberg AJ
Cancer Prev Res (Phila); 2008 Nov; 1(6):485-93. PubMed ID: 19138996
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the formation of benzo[a]pyrene adducts to DNA in A549 lung cells exposed to mixtures of polycyclic aromatic hydrocarbons.
Genies C; Jullien A; Lefebvre E; Revol M; Maitre A; Douki T
Toxicol In Vitro; 2016 Sep; 35():1-10. PubMed ID: 27196671
[TBL] [Abstract][Full Text] [Related]
15. DNA adducts formation and induction of apoptosis in rat liver epithelial 'stem-like' cells exposed to carcinogenic polycyclic aromatic hydrocarbons.
Topinka J; Marvanová S; Vondrácek J; Sevastyanova O; Nováková Z; Krcmár P; Pencíková K; Machala M
Mutat Res; 2008 Feb; 638(1-2):122-32. PubMed ID: 17961608
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of the AhR/ARNT complex by TGF-β/Smad signaling represses
Nakano N; Sakata N; Katsu Y; Nochise D; Sato E; Takahashi Y; Yamaguchi S; Haga Y; Ikeno S; Motizuki M; Sano K; Yamasaki K; Miyazawa K; Itoh S
J Biol Chem; 2020 Jul; 295(27):9033-9051. PubMed ID: 32409577
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism.
Wohak LE; Krais AM; Kucab JE; Stertmann J; Øvrebø S; Seidel A; Phillips DH; Arlt VM
Arch Toxicol; 2016 Feb; 90(2):291-304. PubMed ID: 25398514
[TBL] [Abstract][Full Text] [Related]
18. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity but not the AhR-mediated activity of PAHs is inhibited by other components of complex mixtures of ambient air pollutants.
Líbalová H; Krčková S; Uhlířová K; Milcová A; Schmuczerová J; Ciganek M; Kléma J; Machala M; Šrám RJ; Topinka J
Toxicol Lett; 2014 Mar; 225(3):350-7. PubMed ID: 24472612
[TBL] [Abstract][Full Text] [Related]
20. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate.
Uno S; Dalton TP; Dragin N; Curran CP; Derkenne S; Miller ML; Shertzer HG; Gonzalez FJ; Nebert DW
Mol Pharmacol; 2006 Apr; 69(4):1103-14. PubMed ID: 16377763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
